Literature DB >> 15793289

Role of lipopolysaccharide and cecal ligation and puncture on blood coagulation and inflammation in sensitive and resistant mice models.

Javier Corral1, José Yélamos, David Hernández-Espinosa, Yolanda Monreal, Ruben Mota, Isabel Arcas, Antonia Miñano, Pascual Parrilla, Vicente Vicente.   

Abstract

The hemostatic system is severely disturbed during endotoxemia, leading to a hypercoagulable state. However, it remains uncertain to what extent hypercoagulability is the critical factor in determining the clinical course rather than just the consequence of a severe systemic inflammatory response. To answer this question, we evaluated the evolution of hemostatic and inflammatory markers, as well as histological features, in mice sensitive and resistant to two models of endotoxemia: lipopolysaccharide-injection and cecal ligation puncture. Genetic (knockout mice) and pharmacological (PJ34) blockade of the nuclear enzyme PARP-1 was used to achieve resistance to the endotoxemia. In both models, endotoxemia resulted in antithrombin deficiency, decreased platelets, and fibrin deposition in organs, which were similar in all groups of mice. By contrast, proinflammatory mediators, inflammatory cell infiltration (especially that mediated by mononuclear cells), and organ degeneration were more intense in sensitive animals. Further studies supported a negative role for the triggering of the coagulation cascade in the mortality associated with the endotoxic shock. Hirudin had a minor effect on cell infiltration and organ damage, despite causing a potent inhibition of fibrin deposition. On the other hand, a sublethal dose of lipopolysaccharide yielded significant fibrin deposition but weak activation of the inflammatory response. Our results suggest that activation of coagulation by endotoxemia is severe and independent of the inflammatory response. However, such activation may act with fibrin deposition to have a minor influence on survival in sepsis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793289      PMCID: PMC1602389          DOI: 10.1016/S0002-9440(10)62329-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

Review 1.  Septic shock: pathogenesis.

Authors:  M P Glauser; G Zanetti; J D Baumgartner; J Cohen
Journal:  Lancet       Date:  1991-09-21       Impact factor: 79.321

2.  Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells.

Authors:  J M de Murcia; C Niedergang; C Trucco; M Ricoul; B Dutrillaux; M Mark; F J Oliver; M Masson; A Dierich; M LeMeur; C Walztinger; P Chambon; G de Murcia
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

3.  Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia.

Authors:  T van der Poll; P M Jansen; W J Montegut; C C Braxton; S E Calvano; S A Stackpole; S R Smith; S W Swanson; C E Hack; S F Lowry; L L Moldawer
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

4.  Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia.

Authors:  D Pajkrt; T van der Poll; M Levi; D L Cutler; M B Affrime; A van den Ende; J W ten Cate; S J van Deventer
Journal:  Blood       Date:  1997-04-15       Impact factor: 22.113

5.  A model for thrombin protection against endotoxin.

Authors:  F B Taylor; A Chang; L B Hinshaw; C T Esmon; L T Archer; B K Beller
Journal:  Thromb Res       Date:  1984-10-15       Impact factor: 3.944

Review 6.  Inflammation, sepsis, and coagulation.

Authors:  C T Esmon; K Fukudome; T Mather; W Bode; L M Regan; D J Stearns-Kurosawa; S Kurosawa
Journal:  Haematologica       Date:  1999-03       Impact factor: 9.941

7.  Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia.

Authors:  Ulla Derhaschnig; Doris Bergmair; Claudia Marsik; Irene Schlifke; John Wijdenes; Bernd Jilma
Journal:  Crit Care Med       Date:  2004-05       Impact factor: 7.598

8.  Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees.

Authors:  T van der Poll; M Levi; S J van Deventer; H ten Cate; B L Haagmans; B J Biemond; H R Büller; C E Hack; J W ten Cate
Journal:  Blood       Date:  1994-01-15       Impact factor: 22.113

9.  Myeloperoxidase as a biomarker of skin irritation and inflammation.

Authors:  M A Trush; P A Egner; T W Kensler
Journal:  Food Chem Toxicol       Date:  1994-02       Impact factor: 6.023

10.  Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.

Authors:  T van der Poll; M Levi; C E Hack; H ten Cate; S J van Deventer; A J Eerenberg; E R de Groot; J Jansen; H Gallati; H R Büller
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  16 in total

1.  PARP-2 deficiency affects the survival of CD4+CD8+ double-positive thymocytes.

Authors:  José Yélamos; Yolanda Monreal; Luis Saenz; Enrique Aguado; Valérie Schreiber; Rubén Mota; Teodomiro Fuente; Alfredo Minguela; Pascual Parrilla; Gilbert de Murcia; Elena Almarza; Pedro Aparicio; Josiane Ménissier-de Murcia
Journal:  EMBO J       Date:  2006-08-31       Impact factor: 11.598

2.  Roles of protease-activated receptors in a mouse model of endotoxemia.

Authors:  Eric Camerer; Ivo Cornelissen; Hiroshi Kataoka; Daniel N Duong; Yao-Wu Zheng; Shaun R Coughlin
Journal:  Blood       Date:  2006-01-24       Impact factor: 22.113

3.  Targeting tumor vasculature with an oncolytic virus.

Authors:  Caroline J Breitbach; Naomi S De Silva; Theresa J Falls; Usaf Aladl; Laura Evgin; Jennifer Paterson; Yang Yang Sun; Dominic G Roy; Julia L Rintoul; Manijeh Daneshmand; Kelley Parato; Marianne M Stanford; Brian D Lichty; Aaron Fenster; David Kirn; Harold Atkins; John C Bell
Journal:  Mol Ther       Date:  2011-03-01       Impact factor: 11.454

4.  Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach.

Authors:  Katarina Raduolovic; Rachel Mak'Anyengo; Berna Kaya; Anna Steinert; Jan Hendrik Niess
Journal:  J Vis Exp       Date:  2018-05-02       Impact factor: 1.355

Review 5.  The pathogenesis of sepsis.

Authors:  Deborah J Stearns-Kurosawa; Marcin F Osuchowski; Catherine Valentine; Shinichiro Kurosawa; Daniel G Remick
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

6.  Role of CD11b+ macrophages in intraperitoneal lipopolysaccharide-induced aberrant lymphangiogenesis and lymphatic function in the diaphragm.

Authors:  Kyung Eun Kim; Young-Jun Koh; Bong-Hyun Jeon; Cholsoon Jang; Jinah Han; Raghu P Kataru; Reto A Schwendener; Jin-Man Kim; Gou Young Koh
Journal:  Am J Pathol       Date:  2009-09-17       Impact factor: 4.307

7.  Coordinated signals from the DNA repair enzymes PARP-1 and PARP-2 promotes B-cell development and function.

Authors:  Ludovic Deriano; José Yélamos; Miguel A Galindo-Campos; Marie Bedora-Faure; Jordi Farrés; Chloé Lescale; Lucia Moreno-Lama; Carlos Martínez; Juan Martín-Caballero; Coral Ampurdanés; Pedro Aparicio; Françoise Dantzer; Andrea Cerutti
Journal:  Cell Death Differ       Date:  2019-04-17       Impact factor: 15.828

Review 8.  PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis.

Authors:  Weronika Wasyluk; Agnieszka Zwolak
Journal:  J Inflamm Res       Date:  2021-05-06

9.  Parp-2 is required to maintain hematopoiesis following sublethal γ-irradiation in mice.

Authors:  Jordi Farrés; Juan Martín-Caballero; Carlos Martínez; Juan J Lozano; Laura Llacuna; Coral Ampurdanés; Cristina Ruiz-Herguido; Françoise Dantzer; Valérie Schreiber; Andreas Villunger; Anna Bigas; José Yélamos
Journal:  Blood       Date:  2013-05-15       Impact factor: 22.113

10.  PARP-2 sustains erythropoiesis in mice by limiting replicative stress in erythroid progenitors.

Authors:  J Farrés; L Llacuna; J Martin-Caballero; C Martínez; J J Lozano; C Ampurdanés; A J López-Contreras; L Florensa; J Navarro; E Ottina; F Dantzer; V Schreiber; A Villunger; O Fernández-Capetillo; J Yélamos
Journal:  Cell Death Differ       Date:  2014-12-12       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.